A Record For Amazon–You Won’t Believe This…
Stocks are slightly lower Monday. Oil is lower, on
warmer than expected temperatures in the Northeast.
Wal-Mart said December same store sales will be in the midpoint of its
1-3% projections.
Insurance and hotel stocks are in focus after the devastating tsunami in
Asia. Watch AIG
(
AIG |
Quote |
Chart |
News |
PowerRating), Ace
(
ACE |
Quote |
Chart |
News |
PowerRating) and Four Seasons
(
FS |
Quote |
Chart |
News |
PowerRating)
Sharper Image
(
SHRP |
Quote |
Chart |
News |
PowerRating) missed badly and cut its Q4 and 2004
outlook, citing disappointing holiday sales.
Amazon
(
AMZN |
Quote |
Chart |
News |
PowerRating) recorded its best one-day sales in history–2.8
million items…that’s 32 items per second. Amazon called the 2004 holiday
season its best ever.
Strong sectors are: Airlines
(
XAL.X |
Quote |
Chart |
News |
PowerRating) +1.02%, Gold
(
XAU.X |
Quote |
Chart |
News |
PowerRating)
+1.13%, Internet
(
GIN.X |
Quote |
Chart |
News |
PowerRating) +1.08%.
Weak sectors are: Oil Services
(
OSX.X |
Quote |
Chart |
News |
PowerRating) -1.59%, Natural Gas
(
XNG.X |
Quote |
Chart |
News |
PowerRating) -1.27%, Semis
(
SOX.X |
Quote |
Chart |
News |
PowerRating) -0.74%.
Â
Dow | +56.46 | 10,82 |
S&P 500 | +4.12 | 1209.57 |
Nasdaq | +6.12 | 2,157.03 |
The dollar is -0.59 at
80.63
Crude Oil is -2.23 at
41.95
Gold is +1.80 to 444.90
ce=”Arial” size=”2″ face=”Arial”>Volume is 423 million on the NYSE and
801 million on the Nasdaq.
Market breadth is negative.
NYSE | Issues | |
Advancing | 1191 | Up Vol 151 |
Declining | 1957 | Down Vol 229 |
Ratio | 1.64 | 1.51 |
Nasdaq |
||
Advancing | 1161 | Up Vol 378 |
Declining | 1811 | Down Vol 372 |
Ratio | 1.55 | 1.01 |
Stocks in the News
Coach
(
COH |
Quote |
Chart |
News |
PowerRating) said they expect same store sales up 25% for the
month.
Adolor
(
ADLR |
Quote |
Chart |
News |
PowerRating) said results for a drug in Phase III trials didn’t
yield statistically significant results.
Introgen Theraputic
(
INGN |
Quote |
Chart |
News |
PowerRating) said it would seek accelerated
approval for its Advexin cancer therapy.
Sirius
(
SIRI |
Quote |
Chart |
News |
PowerRating) reached its goal of 1 million subscribers.
Brice Wightman